- Research works
- 21 ▲ 29% vs 2013–17
- Citations
- 337 16.2 per fractional work
- Top-10% rate
- 12.4% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Elea (Argentina) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Elea (Argentina)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Cancer Immunotherapy, Glycosylation, Monoclonal Antibodies, Immunotherapy, Cancer Therapy, Immunity and Tumor Regression.
- Polymer Composite Materials
- Climate Change
- Dendritic Cells
- Tumor Regression
- Inflammation
- Cancer Therapy
- Monoclonal Antibodies
- Cancer Immunotherapy
- Cancer
- Glycosylation
- Immunotherapy
- Immunity
- Innate Immunity
- Antigen Presentation
- Carbon Fiber Reinforced Plastics
- Epidemiology
- Renewable Energy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cancer3▲ 8.9×10 topics
- Cancer Immunotherapy2▲ 62×2 topics
- Glycosylation2▲ 39×2 topics
- Monoclonal Antibodies2▲ 59×2 topics
- Immunotherapy2▲ 12×7 topics
- Cancer Therapy1▲ 9.8×7 topics
- Immunity1▲ 18×3 topics
- Inflammation1▲ 2.5×6 topics
- Innate Immunity1▲ 17×2 topics
- Tumor Regression1▲ 67×2 topics
- Antigen Presentation1▲ 55×1 topic
- Dendritic Cells1▲ 48×1 topic
- Carbon Fiber Reinforced Plastics1▲ 119×1 topic
- Climate Change1▲ 1.81×1 topic
- Epidemiology1▲ 1.22×11 topics
- Polymer Composite Materials1▲ 119×1 topic
- Renewable Energy1▲ 4.8×1 topic
Which research topics does Elea (Argentina) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Angiogenesis and VEGF in Cancer, Veterinary Oncology Research and Biosimilars and Bioanalytical Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 2 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
- 3 Veterinary Oncology Research Pulmonary and Respiratory Medicine 0 works
- 4 Biosimilars and Bioanalytical Methods Immunology 0 works
- 5 Cancer Research and Treatments Biotechnology 0 works
- 6 Glycosylation and Glycoproteins Research Molecular Biology 0 works
- 7 Peptidase Inhibition and Analysis Oncology 0 works
- 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 9 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 10 Hippo pathway signaling and YAP/TAZ Cell Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Elea (Argentina)'s research output changed?
Output in 2018–2022 was 29% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Buenos Aires
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Universidad de Buenos Aires
- Fundación Ciencias Exactas y Naturales
- Hospital Italiano de Buenos Aires
- Comisión Nacional de Energía Atómica
- Pontificia Universidad Católica Argentina
- National University of General San Martín
- National Technological University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.